OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
1.950
-0.050 (-2.50%)
May 9, 2025, 11:17 AM - Market open
OnKure Therapeutics Employees
OnKure Therapeutics had 46 employees as of December 31, 2024.
Employees
46
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,283,957
Market Cap
26.20M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OKUR News
- 3 days ago - OnKure Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 2 months ago - OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - OnKure Therapeutics to Present at Upcoming Leerink and Stifel Investor Conferences - GlobeNewsWire
- 5 months ago - OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219 - GlobeNewsWire
- 5 months ago - OnKure Announces New Date for Upcoming Investor Call - GlobeNewsWire
- 6 months ago - OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium - GlobeNewsWire
- 7 months ago - OnKure: Looking To Alter PI3K Inhibitor Targeting In Breast Cancer And Beyond - Seeking Alpha